Radio Frequencies Used To Kill Inoperable Liver Tumors At Penn's Cancer Center

March 23, 1998

By transforming radio signals into a surgical laser, surgeons at the University of Pennsylvania Cancer Center are using high-energy radio frequency sound waves to destroy inoperable primary and metastatic liver tumors. The powerful procedure -- called radio frequency ablation -- is available exclusively in the Delaware Valley region at Penn's Cancer Center... and available at only a few select hospitals across the nation.

This technology enhances a surgeon's ability to access and successfully treat liver tumors -- which are commonly deemed "inoperable" due to their anatomical position inside the organ itself. "Many patients exhibit tumors in the liver that cannot be removed safely while still preserving the remaining organ," explains Frank Spitz, MD, Assistant Professor of Surgery at Penn. "Or, a patient may have multiple tumors that make surgical extraction next to impossible." To get at those formerly inaccessible tumors via radio frequency ablation, surgeons use ultrasound as a visual roadmap to guide a needle-sized probe directly into the center of the cancerous tumor. Once inside the tumor, the tip of the probe is carefully opened to permit heat- delivering wire extensions to penetrate across a larger area of the tumor. Fully extended, the wire extensions resemble an opened umbrella against the tumor. Finally, the surgeon literally chars the tumorous tissue by zapping up to 100 watts of heat through the probe tip and attached tentacle-like extensions. The heat--similar to what is generated by a microwave oven--kills the tumor. Once all the tumor cells are dead, the body absorbs this tissue over time and no resection of the tumor is needed.

In a recently approved protocol, Penn's cancer specialists are studying the effectiveness of radio frequency ablation in destroying tumors. "We hope that the study results will indicate that the technique completely destroys tumors so that patients who, at this time, aren't able to undergo surgical removal of their tumors will have the option of the radio frequency ablation in the near future," notes Doug Fraker, MD, Chief of Surgical Oncology at Penn and principal investigator of the study. "This strategy to control tumors is the flipside of cryosurgery, which is a technique that has been available for over ten years, where very cold temperatures are used to freeze tumors in the liver. With radio frequency ablation, the heater probe has served advantageous over cryosurgery because a much smaller probe is used, which ultimately decreases vascular complications," Fraker concludes.
-end-
--Doug Fraker, MD, Chief of Surgical Oncology, can be reached at (215) 662-7866.

--Frank Spitz, MD, Assistant Professor of Surgery, can be reached at (215) 614-0857.



University of Pennsylvania School of Medicine

Related Tumor Cells Articles from Brightsurf:

A more sensitive way to detect circulating tumor cells
Breast cancer is the most frequently diagnosed cancer in women, and metastasis from the breast to other areas of the body is the leading cause of death in these patients.

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

How to prevent the spread of tumor cells via the lymph vessels
Scientists from the German Cancer Research Center and the Mannheim Medical Faculty of the University of Heidelberg identified a new way to block the dangerous spread of tumor cells via lymphatic vessels.

The CNIO reprograms CRISPR system in mice to eliminate tumor cells without affecting healthy cells
CNIO researchers destroyed Ewing's sarcoma and chronic myeloid leukaemia tumor cells by using CRISPR to cut out the fusion genes that cause them.

Feeding off fusion or the immortalization of tumor cells
Despite all recent progress, cancer remains one of the deadliest human diseases.

How do tumor cells divide in the crowd?
Scientists led by Dr. Elisabeth Fischer-Friedrich, group leader at the Excellence Cluster Physics of Life (PoL) and the Biotechnology Center TU Dresden (BIOTEC) studied how cancer cells are able to divide in a crowded tumor tissue and connected it to the hallmark of cancer progression and metastasis, the epithelial-mesenchymal transition (EMT).

How tumor cells evade the immune defense
Scientists are increasingly trying to use the body's own immune system to fight cancer.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

New pathway to attack tumor cells identified
A study led by the Institut de Neurociències (INc-UAB) describes a new strategy to tackle cancer, based on inducing a potent stress in tumor causing cell destruction by autophagy.

Nutrient deficiency in tumor cells attracts cells that suppress the immune system
A study led by IDIBELL researchers and published this week in the American journal PNAS shows that, by depriving tumor cells of glucose, they release a large number of signaling molecules.

Read More: Tumor Cells News and Tumor Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.